Earth Science Tech, Inc. (ETST): Results of Operations and Financial Condition
Earth Science Tech, Inc. (ETST) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Earth Science Tech, Inc. Reports Fiscal Year-End Financial Results for March 31, 2026 MIAMI, June 18, 2026 (GLOBE NEWSWIRE) — Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring
How this was made
The 30-second read
Why it matters
FY results show modest top-line growth and improved profitability, alongside continued share repurchases; traders may re-rate the stock ahead of the next quarterly update.
Market read
Fresh FY financial metrics plus explicit buyback activity are the main catalysts for near-term positioning and expectations into the next earnings window.
What to watch
The filing excerpt emphasizes revenue/net income and assets but provides limited detail on operating cash flow, gross margin trend, and leverage/lease obligations—key for assessing durability into Q1 2027.
Background
ETST is an OTC strategic holding company building a vertically integrated healthcare platform (telemedicine, compounding pharmacy, fulfillment).
Ticker impact
ETST filed an 8-K with FY ended Mar 31, 2026 results: revenue $35.7M (+8%), net income $3.6M (+11%), and balance-sheet strengthening.
Likely modest positive bias as traders price in improved profitability and continued share repurchases, though OTC liquidity can amplify volatility.
The article discloses specific FY financial results and states buybacks (4.0M shares retired in FY; 3.1M shares bought in fiscal Q1 2027), both actionable for positioning into the next quarterly report.
Market effects
Adds datapoints for vertically integrated telemedicine/pharmacy/fulfillment holding companies on profitability and cash-flow direction, but impact is company-specific.
No clear regional spillover beyond OTC healthcare/telehealth sentiment.
Limited global relevance; primarily affects ETST trading and small-cap healthcare read-through.
Counterpoint
Buyback-driven EPS support may mask underlying operating cash-flow quality or margin sustainability; balance-sheet growth could reflect working-capital swings.
Key entities
- companyEarth Science Tech, Inc.
OTC-listed holding company reporting FY ended Mar 31, 2026 financial results and ongoing share repurchases.
- personGiorgio R. Saumat
CEO and Chairman who highlighted integration progress and buyback activity.
